Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies
Berberine, the main bioactive component of Coptis chinensis Franch., is widely used in the treatment of diabetes. Previous studies have reported that berberine supplementation may play a multitarget therapeutic role in diabetes-related cognitive impairment (DCI). This systematic review and meta-anal...
Main Authors: | Yanwei Hao, Jiaxin Li, Shengnan Yue, Shaofeng Wang, Shuangyuan Hu, Bin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.917375/full |
Similar Items
-
Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis
by: Lijuan Dan, et al.
Published: (2024-01-01) -
Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
by: Shuangyuan Hu, et al.
Published: (2022-09-01) -
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
by: Ning-Ning Yuan, et al.
Published: (2019-05-01) -
Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis
by: Jianhao Xu, et al.
Published: (2019-06-01) -
Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
by: Mahila Lotfi Aski, et al.
Published: (2018-01-01)